FDA Approved: AZITHROMYCIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for azithromycin submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Bronchitis
• Cervicitis
• Community-acquired Pneumonia
• Nongonococcal Urethritis
• Otitis Media
• Pelvic Inflammatory Disease
• Pharyngitis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

SUPPL AP for AZITHROMYCIN (AZITHROMYCIN)